CAR macrophage tumor tech created by UPenn star scientists gets $53M
A couple of star scientists at UPenn just got financial backing from AbbVie and other investors to come at solid tumors in an unusual way …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
